Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3006 |
|
Actual shortage: | 229 (8%) | |
Anticipated shortage: | 21 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2747 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
27 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ABACAVIR-LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2019-04-22 | 2019-07-29 | 82102 |
APO-TOPIRAMATE | 25MG | TABLET | Resolved | 2019-04-24 | 2019-07-19 | 82340 |
APO-MOXIFLOXACIN | 400MG | TABLET | Resolved | 2018-04-10 | 2019-07-17 | 45365 |
APO-METHYLPHENIDATE ER | 27MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-18 | 2019-07-17 | 69918 |
APO-METHYLPHENIDATE ER | 36MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-19 | 2019-07-17 | 70146 |
APO-DORZO-TIMOP | 5MG 20MG | SOLUTION | Resolved | 2017-03-10 | 2019-07-13 | 290 |
APO-DILTIAZ CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-02-24 | 2019-07-12 | 76714 |
APO-DILTIAZ CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-02-13 | 2019-07-12 | 75614 |
APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-03-13 | 2019-07-12 | 78484 |
APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-02-06 | 2019-07-12 | 74872 |
APO-ALENDRONATE | 70MG | TABLET | Resolved | 2019-06-12 | 2019-07-12 | 86271 |
APO-METHYLPHENIDATE | 20MG | TABLET | Resolved | 2019-05-29 | 2019-07-12 | 85156 |
APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2019-03-20 | 2019-07-06 | 79048 |
APO-VERAP TABLET 120MG | 120MG | TABLET | Resolved | 2019-05-29 | 2019-07-05 | 85164 |
APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2019-05-15 | 2019-07-05 | 84163 |
APO-DILTIAZ CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-02-13 | 2019-07-05 | 75611 |
APO-DILTIAZ CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-02-21 | 2019-07-05 | 76585 |
APO-GABAPENTIN | 600MG | TABLET | Resolved | 2019-03-13 | 2019-07-04 | 78505 |
APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-06-12 | 2019-07-02 | 86347 |
APO-VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-06-12 | 2019-06-24 | 86364 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-NORTRIPTYLINE | 10MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1145 |
APO-NIZATIDINE | 300MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1135 |
APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
APO-METOCLOP TAB 5MG | 5mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1105 |
APO-METOCLOP TAB 10MG | 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1101 |
APO-LISINOPRIL/HCTZ | 25MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1096 |
APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
APO-DILTIAZ TZ | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1078 |
APO-DILTIAZ TZ | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1075 |
APO-DILTIAZ TZ | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1072 |
APO-DILTIAZ TZ | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1069 |
APO-DILTIAZ TZ | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1064 |
APO PREDNISONE TAB 1MG USP | 1MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1056 |